🦊/Investors

Gurnet Point Capital

Pre-Seed–Late Stage · 3 people tracked

Find your way into Gurnet Point Capital

1,692 people in our graph share verified history with the Gurnet Point Capital team — schools, employers, funds. One of them is your warm intro.

Niki Pezeshkiunlockedknows Michael Bucella · together at Goldman Sachs (overlapped)
×9knows the team · via Goldman Sachs
knows the team · via Younited
knows the team · via Fordham University
Fox Verdict
Sign up to see your fit

Investment thesis

B-FLEXION invests across transformative industries with a particular focus on life sciences. The firm conducts seed investments, acquires operating businesses, and develops strategic partnerships while maintaining a dedicated practice for biopharma, diagnostics, and innovative healthcare service providers.

Invests inBiotechHealthtechMedical DevicesSector Agnostic

Source: firm website, verified Jul 21, 2026.

Stage
Pre-Seed–Late Stage
Instruments
Equity
Tracked investments
3

Team · 3 people

from curated

What they invest in

from 3 of 3 portfolio companies

Biotech ×3Healthtech ×2Data & Infrastructure ×1Digital Health ×1Medical Devices ×1

HQs:United States×3

Investments · 3 tracked

founders shown can be your intro path

By year:2022 · 12016 · 12 dated

Macrolide Pharmaceuticalsin

BiotechWatertown, US

Edward Mascioli(Executive Officer)Andrew Myers(Director)

BoardMarkus Goebel(Director)Henry Skinner(Director)inVikas Goyal(Director)Raj Parekh(Director)in

Co-investorsAdvent Life SciencesNovartis Venture FundRoche Venture Fund

Naverisnaveris.comin𝕏Sep 2022 · $51M

Naveris develops and commercializes liquid biopsy tests for the early detection and monitoring of HPV-associated cancers, particularly head and neck and anal cancers.

BiotechData & InfrastructureDigital HealthHealthtechMedical DevicesWaltham, US

James McNally(Executive Officer, Director)inPiyush Gupta(Executive Officer, Director)

BoardAnne Stone(Director)Francis Crispino(Director)Philip Grahame Haydon(Director)

Co-investorsTechU Ventures

Tremeau Pharmaceuticalstremeau.cominOct 2016

Tremeau develops non-opioid pain therapies for patient populations with high unmet medical needs.

BiotechHealthtechCambridge, US

Bradford C. Sippy(Executive Officer, Director)Benjamin Enerson(Executive Officer)Mark Corrigan(Executive Officer)in

Frequently asked questions

What stage does Gurnet Point Capital invest at?
Gurnet Point Capital invests at the Pre-Seed, Seed, Late Stage stages.
What sectors does Gurnet Point Capital focus on?
Gurnet Point Capital focuses on Biotech, Healthtech, Medical Devices, Sector Agnostic.

Similar investors

Featured in lists